✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹1,938 Cr.
P/E
29.32
About
SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India with world-class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO … Read more
SMS Pharmaceuticals Ltd is one of the leading pharmaceutical manufacturing companies in India … Read more
Low
175
52W Range
High
398
  • SMS Pharmaceuticals
  • IOL Chem & Pharma
  • Bajaj Healthcare
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
100 %
(as of Mar 20)
Migrane Medication Market Share in Mexico
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Asset Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on SMS Pharmaceuticals Ltd. Business

    SMS Pharmaceuticals Ltd is a leading Indian pharmaceutical manufacturer with state-of-the-art facilities meeting international standards. The company received export house status in 1997-98 and serves a growing global and local customer base.

    SMS Pharmaceuticals major competitors are IOL Chem & Pharma, Bajaj Healthcare, Themis Medicare, Solara Active Pharma, Morepen Laboratories, Hester Biosciences, Shree Ganesh Remed..
    Market Cap of SMS Pharmaceuticals is ₹1,886 Crs.
    While the median market cap of its peers are ₹1,796 Crs.

    SMS Pharmaceuticals seems to be less financially stable compared to its competitors.
    Altman Z score of SMS Pharmaceuticals is 4.03 and is ranked 5 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar Jun Aug Sep Dec Sep Dec
    Conference Call Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Sep
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material